• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Challenges and prospects in treating macrolide-resistant Bordetella pertussis in Chinese paediatric practice.

作者信息

Yang Ruling, Xu Hongmei, Zhang Zhenzhen, Liu Quanbo, Wu Xiaoying

机构信息

Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, The First Batch of Key Disciplines On Public Health in Chongqing, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing 400014, China.

Department of Infectious Diseases, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, The First Batch of Key Disciplines On Public Health in Chongqing, Chongqing Key Laboratory of Child Rare Diseases in Infection and Immunity, Chongqing 400014, China.

出版信息

J Infect. 2024 Jul;89(1):106185. doi: 10.1016/j.jinf.2024.106185. Epub 2024 May 18.

DOI:10.1016/j.jinf.2024.106185
PMID:38763390
Abstract
摘要

相似文献

1
Challenges and prospects in treating macrolide-resistant Bordetella pertussis in Chinese paediatric practice.中国儿科实践中治疗大环内酯类耐药百日咳博德特氏菌的挑战与前景
J Infect. 2024 Jul;89(1):106185. doi: 10.1016/j.jinf.2024.106185. Epub 2024 May 18.
2
In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: A single-centre study in Zhejiang Province, China.体外活性及大环内酯类、头孢哌酮-舒巴坦和哌拉西林/他唑巴坦对百日咳博德特氏菌的临床疗效及这些分离株引起的百日咳患者临床表现：中国浙江省的一项单中心研究。
J Glob Antimicrob Resist. 2019 Sep;18:47-51. doi: 10.1016/j.jgar.2019.01.029. Epub 2019 Jan 30.
3
High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016.2014-2016 年中国大陆地区大环内酯类耐药百日咳博德特氏菌流行率高及 ptxP1 基因型占主导地位。
Emerg Infect Dis. 2019 Dec;25(12):2205-2214. doi: 10.3201/eid2512.181836.
4
Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance.中国上海 2016-2017 年婴幼儿百日咳鲍特菌感染：临床特征、抗原基因的基因型变异及大环内酯类耐药性。
Pediatr Infect Dis J. 2019 Apr;38(4):370-376. doi: 10.1097/INF.0000000000002160.
5
The First Report of Macrolide-Resistant Bordetella pertussis Isolation in Japan.日本首例大环内酯类耐药百日咳博德特氏菌的分离报告。
Jpn J Infect Dis. 2020 Sep 24;73(5):361-362. doi: 10.7883/yoken.JJID.2019.421. Epub 2020 Apr 30.
6
Pertussis upsurge, age shift and vaccine escape post-COVID-19 caused by ptxP3 macrolide-resistant Bordetella pertussis MT28 clone in China.中国 ptxP3 大环内酯类耐药博德特氏菌 MT28 克隆引起的 COVID-19 后百日咳疫情抬头、年龄偏移和疫苗逃逸。
Clin Microbiol Infect. 2024 Nov;30(11):1439-1446. doi: 10.1016/j.cmi.2024.08.016. Epub 2024 Aug 28.
7
Effect of Macrolides and β-lactams on Clearance of Bordetella pertussis in the Nasopharynx in Children With Whooping Cough.大环内酯类和β-内酰胺类药物对百日咳患儿鼻咽部博德特氏菌清除率的影响。
Pediatr Infect Dis J. 2021 Feb 1;40(2):87-90. doi: 10.1097/INF.0000000000002911.
8
Resurgence of , including one macrolide-resistant isolate, France, 2024.法国 2024 年出现了 ，包括一个耐大环内酯的分离株。
Euro Surveill. 2024 Aug;29(31). doi: 10.2807/1560-7917.ES.2024.29.31.2400459.
9
Macrolide-resistant strain identified during an ongoing epidemic, Finland, January to October 2024.2024年1月至10月，芬兰在一场持续的疫情中发现了耐大环内酯类菌株。
Euro Surveill. 2024 Dec;29(49). doi: 10.2807/1560-7917.ES.2024.29.49.2400765.
10
Appearance of macrolide-resistant Bordetella pertussis strains in China.中国出现大环内酯类耐药百日咳博德特氏菌菌株。
Antimicrob Agents Chemother. 2013 Oct;57(10):5193-4. doi: 10.1128/AAC.01081-13. Epub 2013 Jul 22.

引用本文的文献

1
Clinical and immunological predictors of severe pertussis in children: a nomogram-based prediction model.儿童重症百日咳的临床和免疫预测因素：基于列线图的预测模型
BMC Infect Dis. 2025 Jul 29;25(1):959. doi: 10.1186/s12879-025-11366-8.
2
Reply: Response to Pertussis in the Post-COVID-19 Era: Resurgence, Diagnosis, and Management.回复：COVID-19 后时代百日咳的应对：复发、诊断与管理
Infect Chemother. 2025 Jun;57(2):329-330. doi: 10.3947/ic.2025.0014. Epub 2025 May 7.